Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Chairman operating in the Health Care space. If you think a Chairman is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Julian Ranger
Chairman & Founder of Digime
After early work integrating as an aeronautical engineer, Julian founded STASYS Ltd in 1987, specialising in data interoperability and the military internet, and grew it to a staff of 230, with subsidiaries in the United States, Germany, Malaysia and Australia prior to its sale to Lockheed Martin in 2005. Julian’s management responsibilities encompassed the complete range from Board level vision, direction and control to business development, operational, finance and technical leadership, including developing the iSMART process used for interoperability management by militaries worldwide today. Julian left Lockheed in 2007 as Vice President International Strategic Development, and set up his angel investment and consultancy business, J Ranger Ltd. Julian has invested and supported over 20 start-up businesses, highlights include: Astrobotic, aiming to be the first commercial lunar landing, rover and exploration business; Hailo, revolutionizing the licenced taxi market worldwide; DataSift, providing intelligent access to the world’s social data streams. Julian continues to build new businesses, currently founder and Chairman of digi.me which is reimagining the personal internet putting users back in control of their own data. Julian is a Chartered Engineer, Fellow of the IMechE and Liveryman of the Worshipful Company of Engineers, and is also a Virgin Galactic Future Astronaut.
Follow Julian Ranger:
About Digime, iBundle, J Ranger, Kantara Initiative, Mobile Ecosystem Forum, Worshipful Company of Engineers: Digi.me allows consumers to gather their personal data and share it with businesses in a mutually beneficial value exchange.
Gabriel Mecklenburg
Co-founder, Executive Chairman of Hinge Health
Follow Gabriel Mecklenburg:
About Hinge Health: Hinge Health is a patient-centered digital clinic for treating chronic musculoskeletal conditions.
Graham Richards
Chairman of Proteorex Therapeutics Inc.
Follow Graham Richards:
About : Expanding horizons to find cures
George Goldsmith
Executive Chairman, Chief Executive Officer & Co-Founder of COMPASS Pathways
George is a serial entrepreneur with significant experience in pharmaceutical regulation. George’s early training and experience was a multi-disciplinary blending of cognitive psychology, clinical psychology and computer science.His first company, The Human Interface Group, was a pioneer in collaborative software and acquired by Lotus Development. George led the Lotus Institute and developed software and services to support high-performance, distributed teamwork. George then created TomorrowLab, which provided strategic guidance to internet businesses in the late 1990s. At the same time, he became a senior advisor to McKinsey & Company’s leadership, and eventually joined McKinsey as CEO of TomorrowLab@McKinsey. Subsequently, as a member of the Young Presidents Organisation (YPO) and its International Board of Directors, George founded YPO Networks. In 2002, George founded Tapestry Networks, an organisation committed to improving leadership performance and governance effectiveness in regulated sectors. He still serves as Tapestry Networks’ Non-Executive Chairman. George also serves on the board of directors for AnaBios, a company redefining drug discovery. He and his wife, Ekaterina Malievskaia MD, live in London.
Follow George Goldsmith:
About COMPASS Pathways: Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.
Jan Spaticchia
Chairman & CEO of Energie Group
Jan Spaticchia is the Founder and Chairman at Empowered Brands.
Follow Jan Spaticchia:
About Be Military Fit, Empowered Brands, Energie Group, Hedgehog Concept: Energie is genuinely like no other fitness club group.
Mark Aichroth
Chairman of Ten Health & Fitness
Follow Mark Aichroth:
About Ten Health & Fitness: Ten Health & Fitness providers offering dynamic reformer pilates, physiotherapy, sports massage, personal training & fitness classes.
Shafik Sachedina
Joint Chairman of Sussex Healthcare
Having an experience in dental surgery, Shafik Sachedina is a qualified dental surgeon. He got his qualifications in 1975 from Guy’s Hospital Medical and Dental School at the University of London. He is currently a Joint chairman in the Sussex Health Care Company, a company dedicated to providing care to homes and support services based in Sussex County in South England. Dr. Shafik himself was born in Dar-es-Salaam Tanzania in the year 1950. Having moved to England, he settled and became a British National and holds many positions in different healthcare companies.
Follow Shafik Sachedina:
About : Award winning group of care homes providing over 25 years of healthcare in Sussex offering a range of quality person-centred services.
Alain Schibl
Executive Chairman of Priv
Follow Alain Schibl:
About : PRIV is a mobile and web platform where clients can book vetted beauty and wellness professionals to their location.
Robin Batchelor
Chairman of Everylife Technologies
Robin has been the cornerstone investor in the company since its initial financing in 2014 and became Chairman of everyLIFE in 2016. Prior to this Robin spent twenty years as an Investment Manager and Managing Director at BlackRock, Merrill Lynch and Mercury Asset Management where his team specialised in managing portfolios of fast growth, energy and energy technology companies around the world. Robin’s interest in the care sector came, like many others, from his growing personal experience of family members requiring top-quality care while living many miles apart.
Follow Robin Batchelor:
About Everylife Technologies: Everylife Technologies transforms social care through its intelligent care management platform, The PASSsystem.
Chas Taylor
Chief Executive Officer & Chairman of Respiratory Motion
Mr. Taylor has over 30 years of experience in the medical technology industry. Recently he was the CEO of Veryan Medical, a Co-founder and Director of Novate Medical, and a Director of BrightWater Medical. All three of these companies were acquired in the last three years. Previously, Mr. Taylor was the Co-founder of MedNova, which was acquired by Abbott Laboratories. Prior to founding and leading these companies, he had a long career with Bard Cardiovascular and General Surgical products where he had roles of increasing responsibility in general management and international sales and marketing.
Follow Chas Taylor:
About : Respiratory Motion ExSpiron is FDA and CE Mark cleared and non-invasively measures minute ventilation, the fundamental unit of breathing.
Quintus Liu
Chairman & CEO of Healthera
Quintus is a professional healthcare entrepreneur and investor who ideated the concept of patient-centric digital care known as Healthera.
Follow Quintus Liu:
About Healthera: Transforming the way a nation delivers its healthcare to its population, from prescriptions to personalised services.
Douglas Dundonald
Chairman of Tharos
Douglas is a founder and director of UK-based technology commercialisation group Scientific Venture Partners Ltd which has built a portfolio of high potential technology-based companies arising from leading research institutions. He has been involved in technology companies both as an investor and director for the last 20 years. He is also a former executive main board member of Anglo Pacific Group plc. When an active member of the House of Lords, he held a position on the council of the Parliamentary Information Technology Committee. He is the honorary consul for Chile in Scotland.
Follow Douglas Dundonald:
About Scientific Venture Partners: Improving equine health and performance through optimised digestion
Vivek Murthy
Co-founder/Chairman of Sabri Thabit Saleh Ahmed
Vice Admiral Vivek H. Murthy was confirmed on December 15, 2014, as the 19th United States Surgeon General. As “America’s Doctor,” Dr. Murthy is responsible for communicating the best available scientific information to the public regarding ways to improve personal and public health. He also oversees the operations of the U.S. Public Health Service Commissioned Corps, comprised of approximately 6,700 uniformed health officers who serve in nearly 800 locations around the world to promote, protect, and advance the health and safety of our nation and our world. Dr. Murthy has devoted himself to improving public health through the lens of service, clinical care, research, education and entrepreneurship. The son of immigrants from India, Dr. Murthy discovered a love for the art of healing early in his childhood while spending time in his father’s medical clinic in Miami, Florida. After attending Miami Palmetto Senior High School, he received his Bachelor’s degree from Harvard and his M.D. and M.B.A. degrees from Yale. He completed his residency training at Brigham and Women’s Hospital and Harvard Medical School where he later joined the faculty as an internal medicine physician and instructor. As a clinician-educator, Dr. Murthy has cared for thousands of patients and trained hundreds of residents and medical students. He regards caring for patients as the greatest privilege of his life. In addition to clinical practice, Dr. Murthy has two decades of experience and perspective improving health in communities around the world. He co-founded VISIONS, an HIV/AIDS education program in India and the United States, which he led for eight years. As its president, he established ten chapters with hundreds of volunteers in both countries and grew the organization’s education programs to reach more than 45,000 youth. Dr. Murthy also co-founded the Swasthya project (“health and wellbeing” in Sanskrit), a community health partnership in rural India, to train women to be health providers and educators. During his five-year tenure with the organization, he established seed funding and helped expand research and direct care programs that reached tens of thousands of rural residents. As a research scientist, Dr. Murthy has conducted laboratory research on vaccine development and studied the participation of women and minorities in clinical trials. His research findings have been published in Science, the Journal of the American Medical Association, and the Journal of the National Cancer Institute. Dr. Murthy is also a healthcare entrepreneur and innovator. He co-founded and chaired a successful software technology company, TrialNetworks, which improves research collaboration and enhances the efficiency of clinical trials around the world. Over a period of seven years, Dr. Murthy and his team took the company from conception to an international enterprise that powers dozens of clinical trials for over 50,000 patients in more than 75 countries. Dr. Murthy also served as the president of Doctors for America, a non-profit organization comprised of more than 16,000 physicians and medical students in all 50 states who work with patients and policymakers to build a high quality, affordable healthcare system for all. As a proven leader who will employ 21st century approaches and technology to modernize the role of the Surgeon General, Dr. Murthy plans to focus his efforts on building partnerships within communities and across numerous sectors of society to address the epidemics of obesity and tobacco-related disease, to reduce the stigma associated with mental illness, to improve vaccination rates and to make prevention and health promotion the backbone of a strong and healthy America. Dr. Murthy firmly believes that our nation’s greatest asset has always been its people. And improving the health of the American people – and our neighbors around the world – will be Dr. Murthy’s highest priority as the U.S. Surgeon General.
Follow Vivek Murthy:
About Sabri Thabit Saleh Ahmed, TrialNetworks: Ph.D. scholar in English
David Schoenfeld
Chairman of YgEia3
Follow David Schoenfeld:
About YgEia3: YgEia3 works with corporations developing comprehensive wellness testing for each company.
Jim Horsburgh
Non-Executive Member – Independent Chairman of Lumeon
Follow Jim Horsburgh:
About : Lumeon is a digital health company providing management care solutions to the healthcare industry.
Gunter Dombrowe
Non-Executive Chairman of Adaptix Ltd
Follow Gunter Dombrowe:
About : Adaptix is transforming planar X-ray – the diagnostic imaging modality most widely used in healthcare worldwide.
Paul Cowan
Founder , Chairman & Chief Executive Officer of Quotient Biodiagnostics
Paul Cowan is our Chief Executive Officer and Chairman of our Board of Directors. Mr. Cowan founded us through the acquisition of Alba Bioscience in 2007. He has a broad range of healthcare industry experience gained through over 15 years of employment within industry and investment banking. Previously, Mr. Cowan served as the Chief Financial Officer of Inveresk Research Group, a global contract research organization that was acquired by Charles River Laboratories in 2004. Prior to joining Inveresk in 2001, Mr. Cowan was a senior executive within the Investment Banking department of Bear Stearns & Co., where he led the European biotechnology practice. Prior to Bear Stearns, Mr. Cowan was a senior executive within the Investment Banking department of Morgan Grenfell (acquired by Deutsche Bank in 1990). Mr. Cowan received a Bachelor of Business in accounting from Queensland University of Technology.
Follow Paul Cowan:
About Quotient Biodiagnostics: Quotient Biodiagnostics develops and manufactures products for use in transfusion diagnostics.
William Haseltine
Chairman and President of ACCESS Health International
William A. Haseltine, PhD, has an active career in both science and business. He was a professor at Harvard Medical School and Harvard School of Public Health from 1976 to 1993, where he was founder and the chair of two academic research departments, the Division of Biochemical Pharmacology and the Division of Human Retrovirology.He is well known for his pioneering work on cancer, HIV/AIDS, and genomics. He has authored more than two hundred manuscripts in peer reviewed journals and is the author of several books, including Affordable Excellence: The Singapore Healthcare Story, published in 2013. He is the founder of Human Genome Sciences, Inc., and served as the chairman and CEO of the company until 2004. He is also the founder of several other successful biotechnology companies. Companies he has founded account for seven drugs currently on the market. He is chairman of the Haseltine Foundation for Science and the Arts. He serves as an advisor and board member of several innovative healthcare companies.
Follow William Haseltine:
About ACCESS Health International, Demetrix: ACCESS Health International is a nonprofit think tank and advisory group dedicated to improving access to high quality.
Chris Hand
Chairman of Abingdon Health
Follow Chris Hand:
About Molecular Vision: Abingdon Health is an innovative technology-led company focused on providing rapid and near-patient medical diagnostic testing solutions.
Quentin Pankhurst
Chairman of MediSieve
Quentin is a world expert in magnetic nanoparticles, and an academic innovator with direct experience in the medical technology sector. In 2007, he founded Endomagnetics to commercialise a device for sentinel node detection in breast cancer, serving the company as CEO until 2010 and as a board member until 2014. He played a key role in CE marking the device, which has treated more than 3,500 patients in 15 countries. A physicist by training, Quentin is the Director of the Healthcare Biomagnetics Laboratory at UCL, where he runs programmes in bio- and nanomagnetism aimed at making practicle advances in the use of magnetic nanoparticles in healthcare. He is a champion of translational R&D, for which he established the UCL Institute of Biomedical Engineering. The objective of the IBME is to bring together UCL’s excellence in academic and clinical R&D – around a thousand staff, fellows, nurses and students in 35 different centres, departments and institutes – to create the world’s best research centre for biomedical engineering.
Follow Quentin Pankhurst:
About Endomag, University College London (UCL): MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
Dr Bruce Roser
Chairman & CSO of Stablepharma Ltd
Dr Bruce Roser MB BS, PhD – Chairman & Founder. Discovered the preservation properties of the resurrection plant. A distinguished international career in biomedical research with 108 refereed papers and 49 patents.
Follow Dr Bruce Roser:
About Stablepharma Ltd: An innovative Biotech, developing a wide range of reformulated thermostable and fridge free StablevaX vaccines
Brian Howlett
Chairman of Oxford Endovascular
Brian Howlett co-founded Vascular Flow Technologies Ltd.
Follow Brian Howlett:
About Accentus Medical, ANGLE, Oxford Endovascular: Oxford Endovascular are developing a novel treatment for treating brain aneurysms.
Brendan McNutt
Founder and Chairman of Bryn Melyn Care
Follow Brendan McNutt:
About Bryn Melyn Care: Bryn Melyn Care is a leading provider of therapeutic residential care, independent education, and integrated clinical services.
Richard Farleigh
Chairman of Oxonica
Richard studied economics and mathematics, before working at the Australian Central Bank and then becoming an investment banker and hedge fund manager. In 1994 Richard branched out on his own as a private backer of emerging businesses. He has since backed over 50 young, mostly UK-based technology companies, including Amino Technologies, ARC International, Celoxica, ClearSpeed Technology, Cmed Group, Radiation Watch, Wolfson Microelectronics, Green Chemicals – and Oxonica. Richard is author of the investment book, Taming the Lion, and has appeared in the BBC series Dragon’s Den. He joined Oxonica in July 2007.
Follow Richard Farleigh:
About Oxonica: Oxonica develops and commercializes advanced nanomaterials for UV protection, security, and biodiagnostics applications.
Alistair Wickens
Chairman of Health Hub
Follow Alistair Wickens:
About Health Hub: Innovative online sales platform that allows users to purchase drugs with real-time price solutions and transparent pricing
Ken Hanna
Chairman of Shooting Star Chase
Ken Hanna was appointed a Non-executive Director on 1 April 2009 and became Audit Committee Chairman on 5 October 2012. Ken was previously Chief Financial Officer of Cadbury plc from 2004 until 2009 and prior to that an Operating Partner of Compass Partners and CFO and then CEO of Dalgety PLC. Ken has also been CFO of United Distillers and Avis Europe plc. He is currently Chairman of Inchcape plc, Aggreko plc and Shooting Star CHASE. Ken is a fellow of the Institute of Chartered Accountants.
Follow Ken Hanna:
About : Shooting Star Chase is a leading children’s hospice charity caring for babies, children and young people with life-limiting conditions
Ken Powell
Executive Chairman of the Board of ReViral
Prior to his current role, Ken had very extensive experience of the Biotechnology sector. In reverse order he was: Executive Chairman of Q-Chip a Cardiff, Wales based life science company developing novel delayed release formulations of drugs (merged with Midatech and the joint company listed on AIM in 2015). Founder and CEO of Arrow Therapeutics Ltd (a specialised antiviral drug discovery company acquired by Astra-Zeneca PLC for $150 million in February 2007). Professor at UCL and Deputy Director of the Wolfson Institute for Biomedical Research where he had responsibility for commercial activity including setting up five biotechnology start-up companies. He was a senior Pharmaceutical executive with the Wellcome Foundation which he decided to leave at the Wellcome/Glaxo merger. He has had a successful academic career in the UK and USA. He is an expert virologist and has been involved in the development of multiple drugs including anti-viral compounds against herpes viruses, HIV, Hepatitis C and RSV.
Follow Ken Powell:
About ReViral: ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
Robert Thong
Chairman & Chief Executive Officer of Multiomic Health
Robert has made the art of consulting his life’s work. As Co-Founder and Executive Chairman of Unleash, he applies a wealth of experience to his personal mission: creating world-beating organisations. A supportive advisor to senior executives, Robert combines experienced know-how with an open mindset, delivering results that keep his clients coming back for more. Moving to the UK from Malaysia as a super-smart, teenage maths whiz, Robert started his career as an actuary. Finding business more interesting than statistical models, it wasn’t long before he decided to pursue the MBA that would introduce him to the world of management consulting. Initially focusing on analytical strategy development and operations improvement across various industries, Robert was soon drawn towards managing strategic change in R&D-driven organisations. Robert’s deep understanding of the inner workings of the pharmaceutical industry combined with his appreciation of a senior executive’s daily pressures, is a rare find indeed. He has not only been the pharmaceutical practice head in major consultancies, held P&L accountability and board positions, Robert has also spent much of his time on the ground understanding the real-life issues facing clients in laboratories, factories, pharmacies and physician offices. Coming from an analytical background himself, Robert had to learn in practice about the importance of managing change and engaging people to ensure lasting results, and was inspired to help clients do the same. Robert is dedicated to his clients winning long-term. After founding a boutique consultancy focused on the management practices of small-to-mid sized outfits competing with Big Pharmas, he decided to follow his true calling: guiding leaders and organisations of all types and sizes to success through people-driven strategy execution.
Follow Robert Thong:
About Multiomic Health, Selvedge Venture: Multiomic Health is building a precision therapeutics discovery platform for metabolic syndrome diseases
Jonathan Glenn
Chairman of Tissue Regenix
Follow Jonathan Glenn:
About Tissue Regenix: Tissue Regenix commercializes innovative technologies in regenerative medicine.
Michael Marshall
Executive Chairman of Marshall of Cambridge Aerospace Limited
Follow Michael Marshall:
About Marshall of Cambridge Aerospace Limited: Marshall of Cambridge (Holdings) Limited is the private holding company of the Marshall family.
Dauren Toleukhanov
Co-Founder and Chairman of BrainPatch
Follow Dauren Toleukhanov:
About BrainPatch: BrainPatch is a Neurotechnology startup disrupting the industry of non-invasive brain stimulation.
Simon Embley
Non Executive Chairman of Roadtohealth Group Ltd
Follow Simon Embley:
About Roadtohealth Group Ltd: We’re Road to Health group & we lead a group of strategic partner organisations with shared mission to help people live healthier, happier.
Noel Brady
Chairman of Moment Health
Noel brings learning and knowledge from previous roles in Government and global ICT, including Belfast Harbour Commissioner, and Financial Non-Executive Director for South Eastern Health Trust. As chairman of Moment Health, Noel supports the CEO and executive team, and leads business development and sales functions. “With more than 42 years experience in business in Northern Ireland, including 16 years in the public sector, I am delighted to chair a company as exciting as Moment Health. As a grandfather and father, I am proud to be involved in an initiative that is entirely focused on producing better outcomes for women and their wider family circle.”
Follow Noel Brady:
About Moment Health: Moment Health is a technology company focusing on providing early intervention for new and expectant parents suffering from antenatal.
Hugh Lloyd-Jukes
CEO and Chairman of Oxehealth
Hugh Lloyd-Jukes is the CEO and Chairman at Oxehealth.
Follow Hugh Lloyd-Jukes:
About Oxehealth: SaaS workflow solution gives carers and custodians more time for hands on care where and when it’s needed most.
Huw Jones
Chief Executive Officer & Executive Chairman of Chronos Therapeutics
Follow Huw Jones:
About Chronos Therapeutics, Evgen Pharma: Chronos Therapeutics is a drug development company focused on the development of drugs for the treatment of age-related diseases.
Bill Potter
Executive Chairman of Futura Medical
William Potter became Chairman in June 2001. He is an adviser to the Nominations Committee and to the Remuneration Committee. He provides advice and expertise on product development matters bringing to bear his considerable experience. He has over 30 years of experience in research and development including bringing new products to market involving a wide range of medical devices. He has extensive knowledge of worldwide regulatory procedures, intellectual property issues and licensing. Dr Potter previously worked at London International Group plc, including seven years as Group Scientific Affairs Director, and at Smith & Nephew plc.
Follow Bill Potter:
About Futura Medical: Futura’s innovation strategy applies advanced science to develop products with compelling commercial potential using our advanced
Tony Cotterill
Founder and Chairman of BridgeHead Software
Tony has worked in IT for more than 30 years with 25 of those years spent building and managing software businesses in the UK, Netherlands and USA. As the founder of BridgeHead Software in 1994, Tony continues to lead the organization globally. He previously managed the European subsidiary of Raxco Software following its merger with UIS, where he had established and led UIS’ overseas divisions to profitability. Tony’s introduction to data and storage management was as an IT Director responsible for providing IT services to the civil engineering community. It was from this experience that he saw the need for an independent software provider that would focus on the complexities in data management.
Follow Tony Cotterill:
About BridgeHead Software: BridgeHead Software delivers data management solutions to healthcare organizations across the globe enabling them to improve patient care.
Maureen Coleman
Executive Chairman of CN Bio Innovations
Mrs Coleman has amassed over 20 years’ experience within the pharmaceutical industry, latterly as VP Global Strategy Development for GlaxoSmithKline. Since 2007 she has been working with a number of investor-backed companies including as founding Chief Executive of NovaThera, a regenerative medicine spin-out from Imperial College London, and as Director, Chairman and Chief Executive of life science spin-out companies from Oxford, Kings College, and Brunel Universities. Mrs Coleman is currently Chairman of Parafricta Ltd, a wound care materials business, and is a Director of MedInnovate Ltd, a technology consultancy spanning the healthcare industry. Mrs Coleman joined CN Bio Innovations in 2009 and became Chairman in 2011. She brings a wealth of sector relevant knowledge to the CNBIO team and experienced leadership in developing early stage life science businesses.
Follow Maureen Coleman:
About CN Bio Innovations, CN Bio Innovations, Parafricta: CN Bio develops human organ-on-a-chip platforms for the testing and development of therapeutics for serious human diseases.
Peter George
Chairman & President of Enigma Holding Group
Follow Peter George:
About Enigma Holding Group: Enigma is an investment company that focuses on the areas of health and wellbeing, sport, learning, community programs, and social housing.
Sumit Jamuar
Chairman & CEO of Global Gene Corp
Sumit S. Jamuar serves as Chairman & CEO of Global Gene Corp, a genomics platform company, with a vision to democratize healthcare through genomics. He was formerly CEO of SBICAP (UK), the European Investment Banking subsidiary of State Bank of India, Managing Director with Lloyds Banking Group, and consultant with McKinsey & Company. He holds a Bachelors in Chemical Engineering from Indian Institute of Technology, Delhi; and an MBA from INSEAD.
Follow Sumit Jamuar:
About Global Gene Corp, The BioIndustry Association: Democratizing genomics to positively disrupt health outcomes for everyone
Alan Taylor
Executive Chairman of Clarity Pharmaceuticals
Dr Alan Taylor has a background as a scientist, investment banker, entrepreneur and investor. Alan is currently very active in the Australian start-up area, investing in, advising and taking an active role within a number of early stage companies. Alan is currently the Executive Chairman at Clarity Pharmaceuticals, a company focused on developing radiopharmaceuticals for the treatment of cancer and other diseases. Alan is also the Chairman and co-founder of Mizzen Group Pty Ltd, a new technology start-up company. Alan is passionate about the commercialisation of Australian science and technologies, either in general technology or the life sciences. Alan has approximately 10 years of investment banking experience, and was until recently an Executive Director and shareholder of Inteq Limited, a boutique Australian investment bank, where he remains on the Board of Directors. Alan has significant experience in capital raisings, mergers and acquisitions, and general corporate advisory. At Inteq, Alan was involved in some of the largest ever medical device transactions in Australia. Alan completed an undergraduate degree in Applied Science at the University of Sydney, where he finished first in his year and won the prestigious University Medal. He completed his Ph.D. in Medicine at the Garvan Institute of Medical Research.
Follow Alan Taylor:
About Clarity Pharmaceuticals: Clarity Pharmaceuticals is a personalized medicine company focused on the treatment of serious disease.
Graham Duff
Chairman of Opinsta
Follow Graham Duff:
About : Opinsta is a single platform to manage defect reporting (QA), health and safety checks, Inspections, 3rd party maintenance and more.
Prof Sir Michael Brady FRS FREng FMedSci
Chairman of Optellum
Follow Prof Sir Michael Brady FRS FREng FMedSci:
About Optellum: Optellum develops an imaging biomarker for smart lung cancer detection.
Stephen Critchlow
Executive Chairman of Evergreen Life
Follow Stephen Critchlow:
About Evergreen Life: Evergreen Life is a personal health app provider that revolutionizes the way people manage their medications.
Edward K. Aldag
Chairman, President and CEO of Medical Properties Trust
Edward K. Aldag is the Chairman, President, and CEO at Medical Properties Trust.
Follow Edward K. Aldag:
About Medical Properties Trust, MPT Operating Partnership: Medical Properties Trust, Inc. bridges the gap between the growing demand for high-quality healthcare.
Ingolv Urnes
Executive Chairman of psHEALTH
Ingolv Urnes is a successful technology entrepreneur based in London with an obsession for process automation. He is the founder of psKINETIC, a leading provider of digital process automation solutions in the UK, which has leveraged Appian extensively for nearly 10 years with customers such as AIG, Bupa, hospital chain BMI, Goldman Sachs. In addition to healthcare, psKINETIC delivers compliance solutions and facilities management – all built on Appian. He is also the founder of ART which uses Appian, AI and sophisticated rules engines to provide automated Referral Management and Care Coordination software to enable better health outcomes at lower cost delivering to NHS organizations. Ingolv was the co-founder of Mobizio, a successful mobile app for nurses in the field, and Active Health Partners, a pioneer in technology-based absence management and occupational health. Prior to his involvement in technology, Ingolv spent a decade as an investment banker with Goldman Sachs in Frankfurt, New York and London. Ingolv is known for his energy and for pushing his teams hard to leverage new technologies to solve big problems.
Follow Ingolv Urnes:
About psHEALTH: Case Management, fieldforce mobilisation
Sheraz Daya
Founder, Chairman & Medical Director of Centre for Sight
Follow Sheraz Daya:
About Centre for Sight: Centre for Sight provides eye care services, from basic diagnostic and therapeutic services to complex operative procedures.
Trevor Smith
Chairman of Bedfont Scientific
Follow Trevor Smith:
About Bedfont Scientific: Bedfont Scientific specializes in the design and manufacture of exhaled breath and gas monitoring instruments.
